Midazolam Side Effects
Applies to midazolam: oral syrup.
Other dosage forms:
Important warnings
This medicine can cause some serious health issues
Oral route (syrup)
Midazolam has been associated with respiratory depression and respiratory arrest, especially when used for sedation in noncritical care settings.
Use only in settings that can provide for continuous monitoring of respiratory and cardiac function.
Common side effects of midazolam
Some side effects of midazolam may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
Less common
- rash
Rare
- blurred vision
- double vision
- gagging
- hiccups
- seeing double
- watering of mouth and drooling
Serious side effects of midazolam
Along with its needed effects, midazolam may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking midazolam:
Less common
- anxiety
- chest pain or discomfort
- choking
- confusion
- difficult or troubled breathing
- drowsiness
- dry mouth
- fast heartbeat
- hyperventilation
- irregular heartbeats
- irregular, fast or slow, or shallow breathing
- irritability
- lightheadedness, dizziness, or fainting
- nausea
- nervousness
- noisy breathing
- pale or blue lips, fingernails, or skin
- restlessness
- shaking
- shortness of breath
- slow or irregular heartbeat
- tightness in the chest
- trouble sleeping
- unable to speak
- unusual tiredness
- weakness
- wheezing
Rare
- attack, assault, or force
- changes in patterns and rhythms of speech
- feeling of constant movement of self or surroundings
- headache
- lack or loss of self-control
- loss of balance
- mood swings
- noisy breathing
- not breathing
- restlessness
- seeing, hearing, or feeling things that are not there
- sensation of spinning
- shakiness and unsteady walk
- sleepiness
- slow to respond
- slurred speech
- trouble in speaking
- unconsciousness
- unsteadiness, trembling, or other problems with muscle control or coordination
Get emergency help immediately if any of the following symptoms of overdose occur while taking midazolam:
Symptoms of overdose
- change in consciousness
- difficulty with coordination
- loss of consciousness
- sleepiness or unusual drowsiness
For healthcare professionals
Applies to midazolam: compounding powder, injectable solution, intramuscular solution, intravenous solution, nasal spray, oral syrup.
General
The most commonly reported side effects with oral formulations include emesis and nausea. Decreased tidal volume/respiratory rate and apnea were most commonly reported with parenteral formulations.[Ref]
Respiratory
Oral:
- Very common (10% or more): Respiratory adverse events (up to 11%)
- Common (1% to 10%): Respiratory depression, hypoxia, laryngospasm, upper airway obstruction, rhonchi, congestion
- Uncommon (0.1% to 1%): Sneezing/rhinorrhea
- Frequency not reported: Apnea, hypercarbia, desaturation, stridor, hiccough
Parenteral:
- Very common (10% or more): Decreased tidal volume/respiratory rate (up to 23.3%), apnea (up to 15.4%)
- Common (1% to 10%): Hiccoughs, coughing, desaturation
- Very rare (less than 0.01%): Dyspnea, hiccup, laryngospasm, respiratory arrest
- Frequency not reported: Respiratory depression
- Postmarketing reports: Bronchospasm, hyperventilation, wheezing, shallow respirations, airway obstruction, tachypnea, dysphonia, yawning, continued phonation[Ref]
Respiratory adverse events included hypoxia, laryngospasm, rhonchi, coughing, respiratory depression, airway obstruction, upper airway congestion, and shallow respirations; these side effects occurred more frequently at higher doses.
Decreased tidal volume/respiratory rate occurred in 23.3% of patients given IV formulations and in 10.8% of patients given IM formulations.
Apnea occurred in 15.4% of patients given IV formulations.[Ref]
Gastrointestinal
Oral:
- Very common (10% or more): Emesis/vomiting (up to 11%)
- Common (1% to 10%): Nausea
- Frequency not reported: Gagging, salivation
Parenteral:
- Common (1% to 10%): Nausea, vomiting
- Very rare (less than 0.01%): Constipation, dry mouth
- Postmarketing reports: Acid taste, excessive salivation, retching, toothache[Ref]
Nervous system
Oral:
- Common (1% to 10%): Sedation/prolonged sedation, somnolence, depressed levels of consciousness
- Frequency not reported: Drooling, dizziness, ataxia, vertigo, dysarthria, loss of balance
Parenteral:
- Common (1% to 10%): Headache, oversedation, drowsiness, seizure-like activity
- Very rare (less than 0.01%): Movement disorder, ataxia, dizziness, seizure, anterograde amnesia
- Frequency not reported: Involuntary movements, hyperactivity, decreased alertness, somnolence, prolonged/postoperative sedation, convulsions/drug withdrawal convulsions, feeling faint, tonic/clonic movements and muscle tremor
- Postmarketing reports: Vasovagal episode, retrograde amnesia, grogginess, athetoid movements, lethargy, slurred speech, paresthesia, loss of balance, lightheadedness, feeling of burning, emergence delirium or agitation[Ref]
Cardiovascular
Oral:
- Common (1% to 10%): Bradycardia, bigeminy
- Frequency not reported: Increased heart rate, cardiac arrest, heart failure, decreased systolic and diastolic blood pressure
Parenteral:
- Common (1% to 10%): Hypotension
- Very rare (less than 0.01%): Bradycardia, cardiac arrest, vasodilation
- Frequency not reported: Thrombophlebitis, thrombosis, variations in blood pressure and pulse rate
- Postmarketing reports: Bigeminy, premature ventricular contractions, tachycardia, nodal rhythm, hematoma, cardiovascular collapse, cardiovascular reactions, severe cardiorespiratory adverse events[Ref]
Local
Parenteral:
- Common (1% to 10%): IM injection site pain, IV site tenderness/pain during injection/redness/induration
- Uncommon (0.1% to 1%): IM injection site induration/redness/muscle stiffness, IV site phlebitis
- Frequency not reported: Injection site erythema, injection site pain
- Postmarketing reports: Hive-like elevation at injection site, warmth or coldness at injection site[Ref]
Psychiatric
Oral:
- Common (1% to 10%): Agitation
- Frequency not reported: Dysphoria, disinhibition, excitation, aggression, mood swings, hallucinations, confusion, inappropriate/adverse behavior, behavioral/emotional disorders, euphonia, libido disorders, restlessness, irritability, delusions, anger eruptions, nightmares, psychosis, physical dependency, withdrawal symptoms, abuse, depression (existing, unobserved depression)
Parenteral:
- Very rare (less than 0.01%): Aggression/aggressiveness, agitation, anger, hallucination, hostility, confusion/confusional state, euphoric mood/euphoria
- Frequency not reported: Rage, excitement/paroxysmal excitement, abuse, physical drug dependence and withdrawal syndrome
- Postmarketing reports: Argumentativeness, nervousness, anxiety, restlessness, sleep disturbance, insomnia, nightmares, dysphoria, irritability, tension, mood changes, dreaming during sleep[Ref]
Dermatologic
Oral:
- Common (1% to 10%): Rash
- Uncommon (0.1% to 1%): Pruritus and urticaria
Parenteral:
- Frequency not reported: Angioedema
- Postmarketing reports: Hives, rash, pruritus, skin reactions[Ref]
Ocular
Oral:
- Frequency not reported: Diplopia, strabismus, blurred vision
Parenteral:
- Common (1% to 10%): Nystagmus
- Postmarketing reports: Blurred vision, diplopia, pinpoint pupils, visual disturbance, difficulty focusing eyes, cyclic movement of the eyelids[Ref]
Other
Oral:
- Frequency not reported: Fatigue, falls
Parenteral:
- Common (1% to 10%): Paradoxical reaction
- Very rare (less than 0.01%): Fatigue, falls, assault/physical assault
- Postmarketing reports: Prolonged emergence from anesthesia, blocked ears, chills, weakness, swelling, dreaming during emergence[Ref]
Hypersensitivity
Oral:
- Frequency not reported: Hypersensitivity
Parenteral:
- Frequency not reported: Hypersensitivity, anaphylactic shock
- Postmarketing reports: Allergic reaction, anaphylactoid reactions[Ref]
Musculoskeletal
Oral:
- Frequency not reported: Muscle weakness, fractures
Parenteral:
- Frequency not reported: Fractures[Ref]
References
1. (2001) "Product Information. Versed (midazolam)." Roche Laboratories
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. Cerner Multum, Inc. "Australian Product Information."
Frequently asked questions
More about midazolam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (142)
- Latest FDA alerts (4)
- Dosage information
- During pregnancy
- Drug class: benzodiazepines
- Breastfeeding
Patient resources
- Midazolam drug information
- Midazolam injection
- Midazolam nasal
- Midazolam (Injection) (Advanced Reading)
- Midazolam (Nasal) (Advanced Reading)
Other brands
Professional resources
- Midazolam, Midazolam Hydrochloride monograph
- Midazolam Injection (FDA)
- Midazolam Injection Hospira (FDA)
- Midazolam Syrup (FDA)
Other brands
Related treatment guides
Further information
Midazolam side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.